Page 8 - Zydus Cadila

It is unlikely for Zydus Cadila to repeat US feat this year, say analysts

Analysts doubt if other Indian firms in the segment will do much better in the formulations business in the US

Zydus Cadila's US arm Nesher Pharma gets 11 observations from USFDA

Nesher Pharma, a 100 per cent subsidiary of Zydus Pharmaceuticals USA, saw USFDA inspection at its two facilities

Zydus Cadila gets USFDA nod to market generic anti-diabetic drug

The tablets will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad

Zydus Cadila receives USFDA nod to market blood pressure lowering drug

It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad

Zydus Cadila gets tentative USFDA nod to market generic acid-reflux drug

The drug is used for treatment of symptoms of gastroesophageal reflux disease and to reduce the risk of stomach ulcers in some people taking pain medicines

Zydus Cadila receives final USFDA approval to market glaucoma drugs

The capsules will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad

Zydus Cadila gets final US FDA approval to market acne treatment drug

It will be manufactured at the group's topical manufacturing facility at Ahmedabad

Zydus Cadila receives final approval to launch two drugs in US market

Zydus Cadila said the drug will be produced at the group's formulations manufacturing facility at SEZ, Ahmedabad

Zydus Cadila gets USFDA nod for Baclofen, a muscle spasm treatment tablet

Zydus Cadila has received final approval from the USFDA to market Baclofen tablets in the strengths of 10 mg and 20 mg

Zydus gets USFDA nod to sell Deferasirox tablets to treat high iron levels

The product will be manufactured at the group's formulations manufacturing facility at special economic zone in Ahmedabad

Zydus Cadila gets US FDA nod to market generic Abacavir for HIV treatment

The approval from the US FDA is for Abacavir and Lamivudine tablets USP in the strength of 600 mg/300 mg, Zydus Cadila said

Zydus Cadila gets USFDA nod to market Clobetasol Propionate cream in US

The cream, "will be manufactured at the group's formulations manufacturing facility at Special Economic Zone (SEZ) Ahmedabad," Zydus Cadila said

Zydus Cadila gets tentative US FDA nod for diabetes drug Linagliptin

Zydus Cadila said the drug will be produced at the group's formulations manufacturing facility at SEZ, Ahmedabad

Zydus Cadila receives USFDA nod for migraine relief drug Zolmitriptan

The Zydus group has more than 203 approvals, and so far filed over 330 abbreviated new drug applications (ANDAs) since it started filings in 2003-04

Zydus faces stiff competition for blockbuster drug in US from Teva Pharma

Teva launched the generic version of Irish firm Shire's Lialda in the US earlier this week

Zydus Cadila gets USFDA nod for cardiac drug Metoprolol Succinate

Cadila Healthcare stock was trading 4.27 per cent up at Rs 385.75 in the afternoon on BSE

Zydus Cadila sees 60% of topline from US by FY20 even as rivals lose share

Company has already received highest number of USFDA approvals since April 2017 and aims to launch 75% of these

Zydus Cadila gets USFDA nod for anti-inflammatory drug

The company has received final approval to market the drug in the strength of 50 mg/vial.

Zydus Cadila gets USFDA nod to market treatment for gout, excess uric acid

The drug is indicated in management of cancer patients who are receiving therapy that spikes serum and urinary uric acids

Zydus Cadila gets USFDA approval for anti-depression drug

Drug will be manufactured at the group's formulations manufacturing facility at Moraiya in Ahmedabad